AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
GIBRALTAR STEEL raised its Q2 forecast from 56-61 cents to 72-75 cents. Shares fell.
EMBARCADERO guided its Q2 outlook below views of 9 cents a share to 7 cents, citing poor sales. Shares fell.
MYLAN LABS will pay $9 mil to settle litigation with Mayne Pharma and Tapestry Pharmaceuticals in exchange for a license to make and sell the cancer drug paclixatel in the U.S. Mylan fell.
KNIGHT TRANSPORTATION'S ...